entity

AQP4 dysregulation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AQP4 dysregulation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
1Hypotheses
2Analyses
1Outgoing
1Incoming
0Experiments
2Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
GLYMPHATIC CLEARANCEassociated_withphenotype0.70

Incoming (1)

SourceRelationTypeStr
iron chelationpreventsdrug0.70

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
AQP4 Dysregulation Promotes Neuroinflammation Through Impair 0.680 neurodegeneration What are the specific molecular mechanis

Mentioning Analyses (2)

Scientific analyses that reference this entity

Can ferroptosis inhibitors prevent BBB disruption and edema formation after card

neurodegeneration | 2026-04-25 | 7 hypotheses Top: 0.760

Senolytic therapy for age-related neurodegeneration

neurodegeneration | 2026-04-01 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (2)

Multi-agent debates referencing this entity

Can ferroptosis inhibitors prevent BBB disruption and edema formation after card

closed · Rounds: 4 · Score: 0.73 · 2026-04-25

What are the mechanisms underlying senolytic therapy for age-related neurodegene

closed · Rounds: 4 · Score: 0.92 · 2026-04-01

Related Research

Hypotheses and analyses mentioning AQP4 dysregulation in their description or question text

No additional research found